Relevancy of drug loading to liposomal formulation therapeutic efficacy

被引:120
作者
Barenholz, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel
关键词
D O I
10.1081/LPR-120017482
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1 / 8
页数:8
相关论文
共 25 条
[1]  
[Anonymous], ENCY PHARM TECHNOLOG
[2]   A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice [J].
Babai, I ;
Samira, S ;
Barenholz, Y ;
Zakay-Rones, Z ;
Kedar, E .
VACCINE, 1999, 17 (9-10) :1223-1238
[3]   A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice [J].
Babai, I ;
Samira, S ;
Barenholz, Y ;
Zakay-Rones, Z ;
Kedar, E .
VACCINE, 1999, 17 (9-10) :1239-1250
[4]   A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains [J].
Babai, I ;
Barenholz, Y ;
Zakay-Rones, Z ;
Greenbaum, E ;
Samira, S ;
Hayon, I ;
Rochman, M ;
Kedar, E .
VACCINE, 2001, 20 (3-4) :505-515
[5]   Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models [J].
Bandak, S ;
Goren, D ;
Horowitz, A ;
Tzemach, D ;
Gabizon, A .
ANTI-CANCER DRUGS, 1999, 10 (10) :911-920
[6]  
Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171
[7]   Liposome application: problems and prospects [J].
Barenholz, Y .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2001, 6 (01) :66-77
[8]  
Barenholz Y, 1998, MEDICAL APPLICATIONS OF LIPOSOMES, P545, DOI 10.1016/B978-044482917-7/50031-4
[9]  
Barenholz Yechezkel, 1995, Journal of Liposome Research, V5, P905, DOI 10.3109/08982109509012690
[10]  
GABIZON A, 1994, CANCER RES, V54, P987